7. Organ and marrow function and laboratory values as follows within 28 days prior to the first dose of cabozantinib: a. Absolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor support b. Platelets >= 100,000/mm^3 c. Hemoglobin >= 9 g/dL d. Bilirubin <= 1.5 × the upper limit of normal (ULN). For subjects with known Gilbert's disease, bilirubin <= 3.0 mg/dL e. Serum albumin >= 2.8 g/dl f. Serum creatinine <= 1.5 × ULN or creatinine clearance (CrCl) >= 50 mL/min. For creatinine clearance estimation, the Cockcroft and Gault equation should be used: Male: CrCl (mL/min) = (140 - age) × wt (kg) / (serum creatinine × 72). Female: Multiply above result by 0.85 g. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) <= 3.0 × ULN h. Lipase<=2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis i. Urine protein/creatinine ratio (UPCR) <= 1 j. Serum phosphorus>=2.5mg/dl,calcium>=8mg/dL,magnesium>=1.2mg/dL and potassium>= 3.0meq/L